Drawing for KYXINKO

USPTO serial 79300480

KYXINKO

Reviewed by CopyMark Law Group

Reg. 6848725Status 700Registered
Filing date
Status date
Registration date
Sep 20, 2022
Examiner
LOBO, DEBORAH E
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with KYXINKO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products, namely, antibiotics, analgesics, anesthetics for surgical and non-surgical use, amino acids for medical use, antiseptics, tranquilizers, collyriums, digestives for pharmaceutical purposes, laxatives, prescription synthetic narcotics; chemical products for medical use, namely, pharmaceuticals for treating schizophrenia; chemical pharmaceuticals preparations for the treatment of central nervous system diseases; medicines for the treatment of headache in the form of tonics; tranquillizers; soporifics; antipsychotics; medicated serums for the treatment of eczema; hormones; contraceptive preparations; vaccines, syringes, vials, cartridges or carpules and ampoules for medical purposes, all sold pre-filled with pharmaceutical preparations in the nature of antipsychotics; implantable subcutaneous pharmaceutical delivery devices sold pre-filled with insulin; implantable drug delivery devices sold pre-filled with contraceptives; Pharmaceuticals, namely, oncological preparations for the treatment of cancer; preparations for the treatment of diseases of the central nervous system; preparations for the treatment of schizophrenia; preparations for the treatment of hormonal disorders; preparations for the treatment of allergies, for disorders of the skin, thrombosis, coagulation diseases, infections, flu, pain and inflammation; tranquilizers, prescription synthetic narcotics, antidepressants, anxiolytics; chemical pharmaceuticals for the treatment of diseases of the central nervous system; disposable syringes sold pre-filled with pharmaceutical preparations for treatment of central nervous system diseasesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 25, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED
Oct 27, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 27, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 27, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 27, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 27, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 15, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Dec 22, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Dec 22, 2022FIMPFINAL DISPOSITION PROCESSED
Dec 20, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 20, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 20, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 5, 2022GPNXNOTIFICATION PROCESSED BY IB
Jul 5, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 5, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 15, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 15, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 15, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 12, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 30, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 30, 2022XAECEXAMINER'S AMENDMENT ENTERED
May 30, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 30, 2022GNEAEXAMINERS AMENDMENT E-MAILED
May 30, 2022CNEAEXAMINERS AMENDMENT -WRITTEN
May 25, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 25, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 21, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 20, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 20, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 13, 2022RFNTREFUSAL PROCESSED BY IB
Feb 24, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 24, 2022RFRRREFUSAL PROCESSED BY MPU
Jan 29, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 28, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2022DOCKASSIGNED TO EXAMINER
Jan 15, 2021MAFRAPPLICATION FILING RECEIPT MAILED
Jan 11, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 7, 2021LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 24, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance